Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

AMRUTANJAN HEALTH CARE LTD.

NSE : AMRUTANJANBSE : 590006ISIN CODE : INE098F01031Industry : Pharmaceuticals & DrugsHouse : Amrutanjan

BSE689.6541.35 (+6.38 %)

PREV CLOSE ( ) 648.30

OPEN PRICE ( ) 655.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 2535

TODAY'S LOW / HIGH ( )646.95 689.90

52 WK LOW / HIGH ( )548.05 829

NSE687.4538 (+5.85 %)

PREV CLOSE( ) 649.45

OPEN PRICE ( ) 654.50

BID PRICE (QTY) 687.45 (19)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 46159

TODAY'S LOW / HIGH( ) 642.10 692.35

52 WK LOW / HIGH ( )544.1 842.9

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 09-09 1936

Management Info

S Sambhu Prasad - Chairman S Sambhu Prasad - Managing Director

Registered Office

Address New 103 (Old 42-45),Luz Church Road,Mylapore,
Chennai,
Tamil Nadu-600004

Phone 044-24994164 / 24994146 / 24994465 / 24994366 / 24669000

Email customercare@amrutanjan.com

Website www.amrutanjan.com

Registrars Details

Cameo Corporate Services Ltd

Subramanian Buildings No 1 ,Club House Road,,Chennai

Listing : BSE, NSE

NEWS

04Nov Amrutanjan Health Care informs about b
Pursuant to Regulation 29(1) of SEBI (Listing Obligations & Disclosu..

18Oct Amrutanjan Health Care informs about u
Pursuant to the Regulation 30 read with Clause 20 of Para A of Part A of..

07Jul Amrutanjan Health Care informs about R
Amrutanjan Health Care has informed that it enclosed the certificate iss..

07Apr Amrutanjan Health Care informs about c
Pursuant to Regulation 74 (5) of the SEBI (Depository Participants) Regu..

17Jul Amrutanjan Health Care informs about l
Amrutanjan Health Care has informed that the Company has received a requ..

Financials

Rs. in Millions

	QTR Sep 25	ANNUAL 25
Net Profit	139.6	508.36
Gross Profit	192.13	691.35
Operating Profit	208.21	758.8
Net Sales	1177	4518.16

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Bharat Parenterals (BSE) 1128.80 (6.39%)	M.Cap ( in Cr)777.96
Lupin (BSE) 2114.10 (1.62%)	M.Cap ( in Cr)96571.84
Panacea Biotec (BSE) 362.70 (9.53%)	M.Cap ( in Cr)2221.56
Emcure Pharma (BSE) 1439.60 (2.18%)	M.Cap ( in Cr)27289.76
Aurobindo Pharma (BSE) 1193.70 (1.81%)	M.Cap ( in Cr)69330.29

Shareholding Pattern

	PROMOTERS	46.52%
	NON-INSTITUTION	38.2%
	MUTUAL FUNDS/UTI	7.55%
	FI/BANKS/INSURANCE	0.09%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
ICICI Pru FMCG Fund(G)	2.51
DSP Small Cap Fund-Reg(G)	0.62

Risk Disclosures on Derivatives

Smart Quotes

AMRUTANJAN HEALTH CARE LTD.